Literature DB >> 26211455

The Japanese version of the Rapid Dementia Screening Test is effective compared to the clock-drawing test for detecting patients with mild Alzheimer's disease.

Yasushi Moriyama1, Aihide Yoshino2, Kaori Yamanaka1, Motoichiro Kato3, Taro Muramatsu3, Masaru Mimura3.   

Abstract

BACKGROUND: The Japanese version of the Rapid Dementia Screening Test (RDST-J) and the clock-drawing test (CDT) are both brief psychometric screening tools used to detect the severity of Alzheimer's disease. It remains unclear, however, which is more effective when screening for mild Alzheimer's disease.
METHODS: We administered the RDST-J and CDT to 250 patients with very mild to severe Alzheimer's disease and to 49 healthy volunteers. Patients with a Mini-Mental State Examination score of 12-26 had Clinical Dementia Rating (CDR) scores from 0.5 to 3. Patients were divided into four groups according to CDR score. We performed one-way factorial anova between the four groups and control subjects based on the CDT and RDST-J scores.
RESULTS: Data analysis revealed that RDST-J could distinguish patients with CDR 0.5 from the controls, but CDT could not. Furthermore, the sensitivity of a RDST-J score ≥8 was 57.1%, with a specificity of 81.0%, and the sensitivity of a RDST-J score ≥9 was 79.6%, with a specificity of 55.1% for discriminating CDR 0.5 from controls.
CONCLUSIONS: RDST-J is a more effective tool than CDT for distinguishing CDR 0.5 from controls.
© 2015 The Authors. Psychogeriatrics © 2015 Japanese Psychogeriatric Society.

Entities:  

Keywords:  Alzheimer's disease; Japanese version of the Rapid Dementia Screening Test; category fluency task; clock-drawing test; number-transcoding task

Mesh:

Year:  2015        PMID: 26211455     DOI: 10.1111/psyg.12144

Source DB:  PubMed          Journal:  Psychogeriatrics        ISSN: 1346-3500            Impact factor:   2.440


  1 in total

1.  Usefulness of the Japanese version of Rapid Dementia Screening Test for mild cognitive impairment in older patients with cardiovascular disease: a cross-sectional study.

Authors:  Takuji Adachi; Yuki Tsunekawa; Akihito Matsuoka; Daisuke Tanimura
Journal:  J Geriatr Cardiol       Date:  2021-04-28       Impact factor: 3.189

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.